ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.

Nicola De Stefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.